Literature DB >> 2173264

Complete nucleotide sequence of the matrix gene of human parainfluenza type 2 virus and expression of the M protein in bacteria.

M Kawano1, H Bando, S Ohgimoto, K Okamoto, K Kondo, M Tsurudome, M Nishio, Y Ito.   

Abstract

The sequence of the M gene of human parainfluenza virus type 2 (PIV-2) has been determined. The sequence contained a large open reading frame with 1131 nucleotides encoding a protein with a calculated molecular weight of 42,312. Comparison of M protein sequence indicated that PIV-2 was more closely related to mumps virus and Newcastle disease virus than to other parainfluenza viruses, Sendai virus (SV), and parainfluenza virus type 3 (PIV-3), indicating a possible subdividing of the Paramyxovirus into two groups. This grouping is consistent with that obtained from analysis of the HN gene. Measles virus and canine distemper virus definitely belong to the subgroup composed of SV and PIV-3. No homology region was found in all the paramyxoviruses compared. However, a tertiary structure may be conserved in each subgroup of paramyxovirus. The M protein of PIV-2 was expressed in bacteria, and the product was recognized by a monoclonal antibody specific for the PIV-2 M protein. The bacterial-expressed protein, however, was heterogeneous and smaller in size.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173264     DOI: 10.1016/0042-6822(90)90155-k

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Characterizations of the human parainfluenza type 2 virus gene encoding the L protein and the intergenic sequences.

Authors:  M Kawano; K Okamoto; H Bando; K Kondo; M Tsurudome; H Komada; M Nishio; Y Ito
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

2.  Novel Atlantic bottlenose dolphin parainfluenza virus TtPIV-1 clusters with bovine PIV-3 genotype B strains.

Authors:  Kirsten C Eberle; John D Neill; Stephanie K Venn-Watson; Jodi L McGill; Randy E Sacco
Journal:  Virus Genes       Date:  2015-07-15       Impact factor: 2.332

3.  The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations.

Authors:  Mario H Skiadopoulos; Leatrice Vogel; Jeffrey M Riggs; Sonja R Surman; Peter L Collins; Brian R Murphy
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Molecular evolution of human paramyxoviruses. Nucleotide sequence analyses of the human parainfluenza type 1 virus NP and M protein genes and construction of phylogenetic trees for all the human paramyxoviruses.

Authors:  K Miyahara; S Kitada; M Yoshimoto; H Matsumura; M Kawano; H Komada; M Tsurudome; S Kusagawa; M Nishio; Y Ito
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

6.  Identification and Molecular Characterisation of Bovine Parainfluenza Virus-3 and Bovine Respiratory Syncytial Virus - First Report from Turkey.

Authors:  Mehmet Ozkan Timurkan; Hakan Aydin; Ahmet Sait
Journal:  J Vet Res       Date:  2019-06-12       Impact factor: 1.744

7.  Legume lectins inhibit human parainfluenza virus type 2 infection by interfering with the entry.

Authors:  Jun Uematsu; Aoi Koyama; Sayaka Takano; Yukari Ura; Miho Tanemura; Sahoko Kihira; Hidetaka Yamamoto; Mitsuo Kawano; Masato Tsurudome; Myles O'Brien; Hiroshi Komada
Journal:  Viruses       Date:  2012-06-29       Impact factor: 5.048

8.  Intranasally administered antigen 85B gene vaccine in non-replicating human Parainfluenza type 2 virus vector ameliorates mouse atopic dermatitis.

Authors:  Hiroshi Kitagawa; Mitsuo Kawano; Keiichi Yamanaka; Masato Kakeda; Kenshiro Tsuda; Hiroyasu Inada; Misao Yoneda; Tadashi Sakaguchi; Akina Nigi; Koumei Nishimura; Hiroshi Komada; Masato Tsurudome; Yasuhiro Yasutomi; Tetsuya Nosaka; Hitoshi Mizutani
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.